Individual- and neighborhood-level socioeconomic status and risk of aggressive breast cancer subtypes in a pooled cohort of women from Kaiser Permanente Northern California
Author(s): Aoki, Rhonda-Lee F; Caan, Bette J; Kushi, Lawrence H; Torres, Jacqueline M; Kroenke, Candyce H; et al.
Cancer. 2021 12 15;127(24):4602-4612. Epub 2021-08-20.
PubMed abstractWhy What You May Not Know About Fecal Immunochemical Testing Matters
Author(s): Allison J
Ann Intern Med. 2019 03 05;170(5):342-343. Epub 2019-02-26.
PubMed abstractPotential intended and unintended consequences of recommending initiation of colorectal cancer screening at age 45 years
Author(s): Liang PS; Allison J; Ladabaum U; Martinez ME; Murphy CC; Schoen RE; Shaukat A; Tinmouth J; Gupta S
Gastroenterology. 2018 10;155(4):950-954. Epub 2018-08-21.
PubMed abstractYield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light.
Author(s): Alsayid, Muhammad M; Singh, Maneesh H MH; Issaka, Rachel R; Laleau, Victoria V; Day, Lukejohn L; Lee, Jeffrey J; Allison, James J; Somsouk, Ma M
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2018 Oct ;16(10):1593-1597.e1. Epub 2018-04-13.
PubMed abstractColonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design
Author(s): Dominitz JA; Allison JE; Guarino PD; et al.
Am J Gastroenterol. 2017 Nov;112(11):1736-1746. Epub 2017-10-10.
PubMed abstractRecommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer
Author(s): Young GP; Allison JE; Winawer SJ; et al.
Cancer. 2016 Mar 15;122(6):826-39. Epub 2016-02-01.
PubMed abstractFaecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Author(s): Tinmouth J; Lansdorp-Vogelaar I; Allison JE.
Gut. 2015 Aug;64(8):1327-37
PubMed abstractAdvances in Fecal Occult Blood Tests: the FIT revolution.
Author(s): Young GP; Symonds EL; Allison JE; Cole SR; Fraser CG; Halloran SP; Kuipers EJ; Seaman HE.
Dig Dis Sci. 2015 Mar;60(3):609-22. doi: 10.1007/s10620-014-3445-3. Epub 2014 Dec 10. Review.
PubMed abstractChallenges and possible solutions to colorectal cancer screening for the underserved
Author(s): Gupta S; Allison J; Martinez ME; et al.
J Natl Cancer Inst. 2014 Apr 1;106(4):dju032. Epub 2014-03-28.
PubMed abstractPopulation Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)
Author(s): Allison JE; Fraser CG; Halloran SP; Young GP
Gut Liver. 2014 Mar;8(2):117-30. Epub 2014-03-11.
PubMed abstractRacial and Ethnic Differences in Health Care Utilization and Outcomes Among Ulcerative Colitis Patients in an Integrated Health-Care Organization
Author(s): Li D; Collins B; Velayos FS; Liu L; Lewis JD; Allison JE; Flowers NT; Hutfless S; Abramson O; Herrinton LJ
Dig Dis Sci. 2014 Feb;59(2):287-94. Epub 2013-10-31.
PubMed abstractMeasurement of Colorectal Cancer Test Use With Medical Claims Data in a Safety-Net Health System
Author(s): Gupta S; Tong L; Anderson P; Rose B; Carter E; Koch M; Argenbright K; Ahn C; Allison J; Skinner CS
Am J Med Sci. 2013 Feb;345(2):99-103.
PubMed abstractIncidence and Mortality of Colorectal Adenocarcinoma in Persons with Inflammatory Bowel Disease from 1998 to 2010
Author(s): Herrinton LJ; Liu L; Levin TR; Allison JE; Lewis JD; Velayos F
Gastroenterology. 2012 Aug;143(2):382-9. Epub 2012 May 15.
PubMed abstractA Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin
Author(s): Fraser CG; Allison JE; Halloran SP; Young GP; on behalf of the Expert Working Group on Fecal Immunochemical Tests for Hemoglobin CCSCWEO
J Natl Cancer Inst. 2012 Jun 6;104(11):810-4. Epub 2012 Apr 2.
PubMed abstractNewer fecal tests: opportunities for professionals in laboratory medicine
Author(s): Fraser CG; Allison JE; Young GP; Halloran SP
Clin Chem. 2012 Jun;58(6):963-5. Epub 2012 Mar 27.
PubMed abstractComparing Fecal Immunochemical Testing: Improved Standardization Is Needed
Author(s): Allison JE; Fraser CG; Halloran SP; Young GP
Gastroenterology. 2012 Mar;142(3):422-4. Epub 2012 Jan 24.
PubMed abstractRole of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel Disease
Author(s): Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE
Am J Gastroenterol. 2011 Dec;106(12):2146-53. Epub 2011 Oct 25.
PubMed abstractPrevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system
Author(s): Velayos FS; Liu L; Lewis JD; Allison JE; Flowers N; Hutfless S; Abramson O; Perry GS; Herrinton LJ
Gastroenterology. 2010 Nov;139(5):1511-8. Epub 2010 Jul 24.
PubMed abstractFIT: a valuable but underutilized screening test for colorectal cancer-it's time for a change
Author(s): Allison JE
Am J Gastroenterol. 2010 Sep;105(9):2026-8.
PubMed abstractIncidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006
Author(s): Abramson O; Allison JE; Velayos FS; Herrinton LJ; et al.
J Pediatr. 2010 Aug;157(2):233-239.e1. Epub 2010 Apr 18.
PubMed abstractColorectal cancer screening guidelines: the importance of evidence and transparency
Author(s): Allison JE
Gastroenterology. 2010 May;138(5):1648-1652.e2. Epub 2010 Mar 6.
PubMed abstractThe best screening test for colorectal cancer is the one that gets done well
Author(s): Allison JE
Gastrointest Endosc. 2010 Feb;71(2):342-5.
PubMed abstractThe imperative of equal funding for studies that evaluate any of the evidence-based, guideline-recommended colorectal cancer screening tests
Author(s): Allison JE
Clin Gastroenterol Hepatol. 2009 Dec;7(12):1269-71. Epub 2009 Aug 18.
PubMed abstractValidity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization
Author(s): Liu L; Allison JE; Herrinton LJ
Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1086-93.
PubMed abstractTiming of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations
Author(s): Lewis JD; Abramson O; Pascua M; Liu L; Asakura LM; Velayos FS; Hutfless SM; Alison JE; Herrinton LJ
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1195-201; quiz 1141-2. Epub 2009 Jul 22.
PubMed abstractScreening for colorectal cancer in a safety-net health care system: access to care is critical and has implications for screening policy
Author(s): Gupta S; Tong L; Allison JE; Carter E; Koch M; Rockey DC; Anderson P; Ahn C; Argenbright K; Skinner CS
Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2373-9.
PubMed abstractTime trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005
Author(s): Herrinton LJ; Liu L; Fireman B; Lewis JD; Allison JE; Flowers N; Hutfless S; Velayos FS; Abramson O; Altschuler A; Perry GS
Gastroenterology. 2009 Aug;137(2):502-11. Epub 2009 May 13.
PubMed abstractStool DNA and occult blood testing for screen detection of colorectal neoplasia
Author(s): Ahlquist DA; Levin TR; Allison JE; Hillman SL; et al.
Ann Intern Med. 2008 Oct 7;149(7):441-50, W81.
PubMed abstractPatterns of infliximab use among Crohn's disease patients in a community setting
Author(s): Pressman AR; Hutfless S; Velayos F; Fireman B; Lewis JD; Allison J; Abramson O; Herrinton LJ
Inflamm Bowel Dis. 2008 Sep;14(9):1265-72.
PubMed abstractNatural history of severe ulcerative colitis in a community-based health plan
Author(s): Allison J; Herrinton LJ; Liu L; Yu J; Lowder J
Clin Gastroenterol Hepatol. 2008 Sep;6(9):999-1003.
PubMed abstractIncidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002
Author(s): Herrinton LJ; Liu L; Lewis JD; Griffin PM; Allison J
Am J Gastroenterol. 2008 Aug;103(8):1998-2006.
PubMed abstractGastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease
Author(s): Altschuler A; Collins B; Lewis JD; Velayos F; Allison JE; Hutfless S; Liu L; Herrinton LJ
Inflamm Bowel Dis. 2008 Jul;14(7):992-9.
PubMed abstractMortality by medication use among patients with inflammatory bowel disease, 1996-2003
Author(s): Hutfless SM; Weng X; Liu L; Allison J; Herrinton LJ
Gastroenterology. 2007 Dec;133(6):1779-86. Epub 2007 Sep 26.
PubMed abstractScreening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics
Author(s): Allison JE; Levin TR; Selby JV; et al.
J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.
PubMed abstractClustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization
Author(s): Weng X; Liu L; Barcellos LF; Allison JE; Herrinton LJ
Am J Gastroenterol. 2007 Jul;102(7):1429-35. Epub 2007 Apr 16.
PubMed abstractEstimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings
Author(s): Herrinton LJ; Liu L; Lafata JE; Allison JE; Andrade SE; Korner EJ; Chan KA; Platt R; Hiatt D; O'Connor S
Inflamm Bowel Dis. 2007 Apr;13(4):451-61.
PubMed abstractColon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FIT
Author(s): Allison JE
Gastroenterology. 2005 Aug;129(2):745-8.
PubMed abstractImmunochemical fecal occult blood tests for colorectal cancer screening
Author(s): Allison JE
Am J Med. 2004 Apr 1;116(7):498; author reply 498-9.
PubMed abstractA randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease
Author(s): Allison JE; Hurley LB; Hiatt RA; Levin TR; Ackerson LM; Lieu TA
Arch Intern Med. 2003 May 26;163(10):1165-71.
PubMed abstractQuality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia
Author(s): Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
Am J Gastroenterol. 2001 Feb;96(2):338-47.
PubMed abstractA comparison of fecal occult-blood tests for colorectal-cancer screening.
Author(s): Allison, JE; Tekawa, IS; Ransom, LJ; Adrain, AL
The New England journal of medicine. 1996 Jan 18;334(3):155-9. Epub --.
PubMed abstract